Marine Cryptophytes Are Great Sources of EPA and DHA

Microalgae have the ability to synthetize many compounds, some of which have been recognized as a source of functional ingredients for nutraceuticals with positive health effects. One well-known example is the long-chain polyunsaturated fatty acids (PUFAs), which are essential for human nutrition. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are the two most important long-chain omega-3 (ω-3) PUFAs involved in human physiology, and both industries are almost exclusively based on microalgae. In addition, algae produce phytosterols that reduce serum cholesterol. Here we determined the growth rates, biomass yields, PUFA and sterol content, and daily gain of eight strains of marine cryptophytes. The maximal growth rates of the cryptophytes varied between 0.34–0.70 divisions day−1, which is relatively good in relation to previously screened algal taxa. The studied cryptophytes were extremely rich in ω-3 PUFAs, especially in EPA and DHA (range 5.8–12.5 and 0.8–6.1 µg mg dry weight−1, respectively), but their sterol concentrations were low. Among the studied strains, Storeatula major was superior in PUFA production, and it also produces all PUFAs, i.e., α-linolenic acid (ALA), stearidonic acid (SDA), EPA, and DHA, which is rare in phytoplankton in general. We conclude that marine cryptophytes are a good alternative for the ecologically sustainable and profitable production of health-promoting lipids.

[1]  J. S. Sinninghe Damsté,et al.  On the potential application of polar and temperate marine microalgae for EPA and DHA production , 2013, AMB Express.

[2]  P. Kris-Etherton,et al.  Dietary reference intakes for DHA and EPA. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.

[3]  D. Orcutt,et al.  Sterol, fatty acid and elemental composition of diatoms grown in chemically defined media. , 1975, Comparative biochemistry and physiology. B, Comparative biochemistry.

[4]  E. Peltomaa,et al.  The Importance of Phytoplankton Biomolecule Availability for Secondary Production , 2017, Front. Ecol. Evol..

[5]  Robert E. Jinkerson,et al.  Ultrastructure and Composition of the Nannochloropsis gaditana Cell Wall , 2014, Eukaryotic Cell.

[6]  Malcolm R. Brown,et al.  Cryptophyceae and rhodophyceae; chemotaxonomy, phylogeny, and application. , 2005, Phytochemistry.

[7]  J. Petrie,et al.  Long-Chain Omega-3 Oils–An Update on Sustainable Sources , 2010, Nutrients.

[8]  Imogen Foubert,et al.  Optimization of an Analytical Procedure for Extraction of Lipids from Microalgae , 2012 .

[9]  S. Heaney,et al.  Diversity in the influence of temperature on the growth rates of freshwater algae, and its ecological relevance , 2004 .

[10]  H. Gerster Can adults adequately convert alpha-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)? , 1998, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[11]  Gregory D. Scholes,et al.  The photophysics of cryptophyte light-harvesting , 2006 .

[12]  O. Pulz,et al.  Valuable products from biotechnology of microalgae , 2004, Applied Microbiology and Biotechnology.

[13]  H. Tanila,et al.  Plant Sterols the Better Cholesterol in Alzheimer's Disease? A Mechanistical Study , 2013, The Journal of Neuroscience.

[14]  C. Gillberg,et al.  Omega-3/Omega-6 Fatty Acids for Attention Deficit Hyperactivity Disorder , 2009, Journal of attention disorders.

[15]  Wolfgang Schramm,et al.  Team , 2018, Spaces of Intensity.

[16]  E. Peltomaa,et al.  Lake eutrophication and brownification downgrade availability and transfer of essential fatty acids for human consumption. , 2016, Environment international.

[17]  P. Coutinho,et al.  Nutritional value of the cryptophyte Rhodomonas lens for Artemia sp. , 2009 .

[18]  I. Leclercq,et al.  Why and How Meet n-3 PUFA Dietary Recommendations? , 2010, Gastroenterology research and practice.

[19]  P. Calder,et al.  Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. , 2005, Reproduction, nutrition, development.

[20]  P. Andrade,et al.  Distinct fatty acid profile of ten brown macroalgae , 2013 .

[21]  L. Cleland,et al.  Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids. , 2003, The American journal of clinical nutrition.

[22]  F. Berenbaum,et al.  Stigmasterol: a phytosterol with potential anti-osteoarthritic properties. , 2010, Osteoarthritis and cartilage.

[23]  Bo-Liang Li,et al.  Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques. , 2011, Cell metabolism.

[24]  Jaime López-Cervantes,et al.  Fatty acids, total lipid, protein and ash contents of processed edible seaweeds , 2004 .

[25]  Jin Liu,et al.  Lipid Production from Nannochloropsis , 2016, Marine drugs.

[26]  M. Sampson,et al.  Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group. , 1993, Diabetes care.

[27]  H. R. Gislerød,et al.  Fatty acid composition of 12 microalgae for possible use in aquaculture feed , 2007, Aquaculture International.

[28]  E. Peltomaa,et al.  Suitability of Phytosterols Alongside Fatty Acids as Chemotaxonomic Biomarkers for Phytoplankton , 2016, Front. Plant Sci..

[29]  C. Wilhelm,et al.  Different phycobilin antenna organisations affect the balance between light use and growth rate in the cyanobacterium Microcystis aeruginosa and in the cryptophyte Cryptomonas ovata , 2012, Photosynthesis Research.

[30]  B. Whitton,et al.  The freshwater alga Chroothece richteriana (Rhodophyta) as a potential source of lipids. , 2014, Food chemistry.

[31]  Radhouan Ben-Hamadou,et al.  Alternative Sources of n-3 Long-Chain Polyunsaturated Fatty Acids in Marine Microalgae , 2013, Marine drugs.

[32]  A. Simopoulos,et al.  The Importance of the Omega-6/Omega-3 Fatty Acid Ratio in Cardiovascular Disease and Other Chronic Diseases , 2008, Experimental biology and medicine.

[33]  M. T. Arts,et al.  Production, distribution, and abundance of long-chain omega-3 polyunsaturated fatty acids: a fundamental dichotomy between freshwater and terrestrial ecosystems , 2015 .

[34]  David L. Parry,et al.  The gross chemical composition and fatty acid composition of 18 species of tropical Australian microalgae for possible use in mariculture , 1999 .

[35]  Xueli Cao,et al.  Sterols from Mytilidae Show Anti-Aging and Neuroprotective Effects via Anti-Oxidative Activity , 2014, International journal of molecular sciences.

[36]  P. Schenk,et al.  Microalgal biofactories: a promising approach towards sustainable omega-3 fatty acid production , 2012, Microbial Cell Factories.

[37]  R. Parra-Saldívar,et al.  Extraction and purification of high-value metabolites from microalgae: essential lipids, astaxanthin and phycobiliproteins , 2014, Microbial biotechnology.

[38]  Malcolm R. Brown,et al.  Nutritional properties of microalgae for mariculture , 1997 .

[39]  D. O'Neal,et al.  Lipids in Health and Disease , 2009 .

[40]  A. Simopoulos An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity , 2016, Nutrients.

[41]  Rocky de Nys,et al.  Growth, lipid content, productivity, and fatty acid composition of tropical microalgae for scale‐up production , 2010, Biotechnology and bioengineering.

[42]  D. Caron,et al.  Relative effects of nitrogen or phosphorus depletion and light intensity on the pigmentation, chemical composition, and volume of Pyrenomonas salina (Cryptophyceae) , 1990 .

[43]  G. Lambrinidis,et al.  Effect of temperature on growth, chemical composition and fatty acid composition of tropical Australian microalgae grown in batch cultures , 2002 .

[44]  R. Deckelbaum,et al.  The omega-3 fatty acid nutritional landscape: health benefits and sources. , 2012, The Journal of nutrition.

[45]  J. Frohlich,et al.  Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis: clinical and experimental evidence. , 1999, The American journal of medicine.